InsiderPresident
Stephen Hoge Insider Trading Activity
Every SEC Form 4 transaction reported by Stephen Hoge, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Stephen Hoge buying or selling?
Stephen Hoge reported 0 open-market buys ($0) and 147 sells ($339.4M) across 147 Form 4 filings at 1 company — a net selling position of $339.4M.
Source: SEC EDGAR Form 4
What stands out
- All 147 of Stephen Hoge's Form 4 filings are for one company, Moderna, Inc. (MRNA).
- The most recent Form 4 was accepted on Oct 16, 2026 (2 days ago).
- In the last 12 months: no open-market purchases and 6 sales ($45.4M).
- The largest open-market sale in the last 12 months was $17.0M of Moderna, Inc. (MRNA) on Oct 16, 2026. SEC ↗
Key Statistics (as of Oct 16, 2026)
Total Form 4 filings
147
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (147)
$339.4M
Insider sentiment
Net sellingNet insider flow of $339.4M in net selling, filed between Jan 14, 2020 – Oct 16, 2026.
Companies Stephen Hoge files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | MRNAModerna, Inc. | 147 |
Recent Stephen Hoge transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | MRNA | President | Sale | 78.4K | $17.0M | SEC ↗ |
| Sep 16, 2026 | MRNA | President | Sale | 80.6K | $11.7M | SEC ↗ |
| Jul 16, 2026 | MRNA | President | Sale | 53.3K | $3.6M | SEC ↗ |
| Jun 17, 2026 | MRNA | President | Sale | 53.3K | $2.7M | SEC ↗ |
| May 18, 2026 | MRNA | President | Sale | 53.3K | $2.6M | SEC ↗ |
| Feb 25, 2026 | MRNA | President | Sale | 160.0K | $7.8M | SEC ↗ |
| Dec 4, 2024 | MRNA | President | Sale | 314 | $13.6K | SEC ↗ |
| Dec 2, 2024 | MRNA | President | Sale | 291 | $12.5K | SEC ↗ |
| Nov 12, 2024 | MRNA | President | Sale | 277 | $12.8K | SEC ↗ |
| Sep 4, 2024 | MRNA | President | Sale | 318 | $24.5K | SEC ↗ |
| Aug 30, 2024 | MRNA | President | Sale | 300 | $23.4K | SEC ↗ |
| Aug 13, 2024 | MRNA | President | Sale | 254 | $21.4K | SEC ↗ |
| Jul 16, 2024 | MRNA | President | Sale | 15.0K | $1.8M | SEC ↗ |
| Jun 18, 2024 | MRNA | President | Sale | 15.0K | $2.1M | SEC ↗ |
| Jun 4, 2024 | MRNA | President | Sale | 339 | $47.7K | SEC ↗ |
| May 30, 2024 | MRNA | President | Sale | 341 | $49.3K | SEC ↗ |
| May 17, 2024 | MRNA | President | Sale | 15.0K | $1.9M | SEC ↗ |
| May 13, 2024 | MRNA | President | Sale | 255 | $30.8K | SEC ↗ |
| Apr 16, 2024 | MRNA | President | Sale | 15.0K | $1.6M | SEC ↗ |
| Mar 19, 2024 | MRNA | President | Sale | 15.0K | $1.5M | SEC ↗ |
| Mar 5, 2024 | MRNA | President | Sale | 309 | $29.2K | SEC ↗ |
| Mar 1, 2024 | MRNA | President | Sale | 2.4K | $225.8K | SEC ↗ |
| Feb 23, 2024 | MRNA | President | Sale | 15.0K | $1.5M | SEC ↗ |
| Feb 16, 2024 | MRNA | President | Sale | 10.5K | $937.0K | SEC ↗ |
| Feb 13, 2024 | MRNA | President | Sale | 304 | $26.2K | SEC ↗ |
Showing the 25 most recent filings of 147. Screen every filing.
Stephen Hoge insider trading FAQ
Is Stephen Hoge buying or selling?
Across 147 SEC Form 4 filings, Stephen Hoge reported 0 open-market purchases totaling $0 and 147 sales totaling $339.4M — a net selling position of $339.4M.
Which companies does Stephen Hoge file Form 4s for?
Stephen Hoge has reported insider transactions at 1 company, most often Moderna, Inc. (MRNA).
How far back does Stephen Hoge's filing history go?
Trabud holds Stephen Hoge's SEC Form 4 filings from Jan 14, 2020 – Oct 16, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Stephen Hoge's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Stephen Hoge and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener